Table 5.
Antiviral evaluation of compounds ( ±)–5a–t against hCoV-229E
Compound | Conc. unit | hCoV-229E (HEL cells) | |
---|---|---|---|
CC50 | EC50 | ||
5b | µM | 81.5 | 4.7 ± 0.5 (*) |
5c | µM | > 100 | 24.4 |
5e | µM | > 100 | > 100 |
5f | µM | > 100 | 3.2 ± 1.8 (*) |
5 g | µM | > 100 | > 100 |
5 h | µM | > 100 | 38.0 |
5j | µM | 23.8 | > 100 |
5 k | µM | > 100 | > 100 |
5 m | µM | > 100 | 95.7 |
5n | µM | > 100 | > 100 |
5p | µM | > 100 | > 100 |
5q | µM | < 0.8 | > 100 |
5r | µM | > 100 | > 100 |
5 s | µM | > 100 | > 100 |
5t | µM | > 100 | > 100 |
UDA | µg/ml | > 100 | 2.1 |
(*)Mean value of three independent experiments ± SEM